NBIX News and Press, Neurocrine Biosciences Inc.

Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum PR Newswire SAN DIEGO , March 10, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that members of the management team will participate at the Stifel 2026 Virtual CNS Forum at 4...

2026-03-09 10:57:58 ET Neurocrine Biosciences, Inc. (NBIX) Leerink Global Healthcare Conference 2026 March 9, 2026 8:40 AM EDT... Read the full article on Seeking Alpha For further details see: Neurocrine Biosciences, Inc. (NBIX) Presents at Leerink Global Healthcare Confere...

BetterInvesting™ Magazine Update on Equifax Inc. (NYSE: EFX) and Neurocrine Bio In. (NASDAQ: NBIX) PR Newswire TROY, Mich. , March 6, 2026 /PRNewswire/ -- Equifax Inc.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy rang...

2026-03-03 14:02:17 ET Neurocrine Biosciences, Inc. (NBIX) TD Cowen 46th Annual Health Care Conference March 3, 2026 11:50 AM EST... Read the full article on Seeking Alpha For further details see: Neurocrine Biosciences, Inc. (NBIX) Presents at TD Cowen 46th Annual Health Ca...

Issued on behalf of Helus Pharma VANCOUVER – Baystreet.ca News Commentary – A growing body of clinical evidence is pushing neuroscience-based therapies from early research into late-stage development, with multiple compounds now approaching regulatory milestones acro...

2026-02-17 10:04:06 ET Danielle Brill from Truist Financial issued a price target of $140.00 for NBIX on 2026-02-17 14:53:40. The adjusted price target was set to $140.00. At the time of the announcement, NBIX was trading at $128.98. The overall price target consensus is...

2026-02-13 04:18:35 ET ... Read the full article on Seeking Alpha For further details see: Neurocrine Biosciences: Growth Beyond Just Ingrezza

2026-02-12 14:16:00 ET Steady execution on sales and clinical development builds value over time for biotechs but tends to be rather boring from a market sentiment standpoint. Neurocrine Biosciences ( NBIX ) is doing the right things to build value for its shareholders, but 2026 is look...

2026-02-11 20:59:11 ET Image source: The Motley Fool. Wednesday, Feb. 11, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-11 20:15:13 ET More on Neurocrine Biosciences Neurocrine Biosciences, Inc. (NBIX) Q4 2025 Earnings Call Transcript Neurocrine Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation Neurocrine Biosciences, Inc. (NBIX) Presents at 44th Annual J.P. Mor...